Should NICE’s cost-effectiveness thresholds change?
We explore the ongoing debate around NICE’s cost-effectiveness thresholds and what the future holds.
Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
We explore the ongoing debate around NICE’s cost-effectiveness thresholds and what the future holds.
For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing.
An end of year summary from our chief executive, Dr Sam Roberts.
We’ve issued final draft guidance recommending a new once-a-day tablet that is set to benefit around 1,100 people with a type of advanced breast cancer.
Best practice resources for practitioners and commissioners.
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
Summaries of evidence and advice on common health topics (CKS)
We are celebrating 25 years of independence, transparency and rigour.
The NICE Conference will explore our continued commitment to deliver relevant, timely and impactful guidance and how we continue to transform to meet the rapidly changing needs of the system.